Nou-Fontanet, Laia
Cantalupo, Gaetano
Braun, Frederik
Camacho, Alia Ramírez
Álvarez, Verónica González
Chilavert, Verónica Delgadillo
Insuga, Víctor Soto
Fernández, Luisa Arrabal
Alonso-Colmenero, Itziar
Arzimanoglou, Alexis
Fons, Carmen https://orcid.org/0000-0001-7227-1350
Article History
Received: 19 September 2025
Accepted: 7 January 2026
First Online: 3 April 2026
Declarations
:
: This study was approved by the local institutional ethics committee (Sant Juan de Déu Hospital ID number: PIC-131–18). All research was conducted in accordance with the principles of the Declaration of Helsinki (2024). Written informed consent to participate was obtained from the parents or legal representatives of all newly described individuals.
: Written informed consent for publication of clinical data was obtained from the parents or legal representatives of all newly described individuals.
: CF has served on scientific advisory board for longboard pharmaceuticals and biocodex and has received speaker honoraria from Nutricia, UCB, and Jazz Pharmaceuticals. The authors declare that there are no other conflicts of interest relevant to this work.